You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • LB0003 Tofacitinib with and without methotrexate versus adalimumab with methotrexate for the treatment of rheumatoid arthritis: results from oral strategy, a phase 3b/4 randomised trial

Article metrics

Article menu

Download PDFPDF

Oral Presentations
From classics to new: synthetic DMARDs in RA
LB0003 Tofacitinib with and without methotrexate versus adalimumab with methotrexate for the treatment of rheumatoid arthritis: results from oral strategy, a phase 3b/4 randomised trial
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20177105
Jul 201778012
Aug 20172602
Sep 201780014
Oct 201712807
Nov 20178407
Dec 201710402
Jan 201890010
Feb 20189203
Mar 20186802
Apr 20184202
May 20182803
Jun 20183001
Jul 20184404
Aug 20185202
Sep 20182805
Oct 20182402
Nov 20182207
Dec 20182205
Jan 20191402
Feb 20192604
Mar 20191406
Apr 20192805
May 2019402
Jun 20191806
Jul 201920014
Aug 20192406
Sep 20191004
Oct 20192607
Nov 20191003
Dec 20191203
Jan 20201001
Feb 2020801
Mar 20202204
Apr 20201004
May 20201202
Jun 20201202
Jul 20201803
Aug 20201408
Sep 20201402
Oct 20201404
Nov 20201804
Dec 2020802
Jan 2021400
Feb 2021402
Mar 2021602
Apr 2021606
May 2021001
Jul 2021009
Aug 2021004
Sep 2021003
Oct 20215017
Nov 20219016
Dec 2021402
Jan 2022403
Feb 2022200
Mar 2022401
Apr 20221803
May 202210010
Jun 20221404
Jul 20221600
Aug 20221005
Sep 202218015
Oct 2022603
Nov 20228010
Dec 2022300
Jan 2023803
Feb 20231004
Mar 20232204
Apr 2023601
May 2023203
Jun 2023803
Jul 2023403
Sep 2023600
Oct 2023200
Nov 20231604
Dec 20231601
Jan 2024801
Feb 2024201
Mar 20241001
Total17500339